35 | AntigensIBA
01/2022
-
06/2005 |
8 | RadiopharmaceuticalsIBA
01/2021
-
06/2005 |
7 | Pharmaceutical PreparationsIBA
11/2021
-
01/2015 |
6 | LigandsIBA
03/2021
-
06/2005 |
6 | AcidsIBA
01/2020
-
01/2010 |
5 | Radioisotopes (Radionuclides)IBA
03/2021
-
01/2010 |
5 | Prostate-Specific Antigen (Semenogelase)IBA
01/2020
-
07/2009 |
5 | Biomarkers (Surrogate Marker)IBA
01/2019
-
07/2009 |
4 | Cysteine (L-Cysteine)FDA Link
10/2017
-
05/2008 |
4 | Urea (Carbamide)FDA LinkGeneric
10/2016
-
12/2008 |
4 | Peptides (Polypeptides)IBA
06/2013
-
07/2009 |
3 | Carbonic Anhydrase IXIBA
01/2021
-
10/2015 |
3 | Proteins (Proteins, Gene)FDA Link
01/2021
-
11/2009 |
3 | Hormones (Hormone)IBA
01/2016
-
06/2005 |
3 | Membrane Proteins (Integral Membrane Proteins)IBA
02/2014
-
06/2005 |
2 | Lysine (L-Lysine)FDA Link
01/2022
-
12/2012 |
2 | LuciferasesIBA
01/2020
-
10/2016 |
2 | FluoridesIBA
12/2018
-
11/2018 |
2 | Indicators and Reagents (Reagents)IBA
10/2017
-
05/2011 |
2 | EnzymesIBA
08/2016
-
05/2011 |
2 | Serine Proteases (Serine Protease)IBA
06/2013
-
07/2009 |
2 | AndrogensIBA
01/2013
-
12/2012 |
1 | avelumabIBA
01/2021 |
1 | durvalumabIBA
01/2021 |
1 | atezolizumabIBA
01/2021 |
1 | Monoclonal AntibodiesIBA
01/2021 |
1 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2020 |
1 | 2- (3- (1- carboxy- 5- (4- iodobenzylamino)pentyl)ureido)pentanedioic acidIBA
01/2020 |
1 | bedaquiline (R207910)IBA
12/2019 |
1 | Anti-Bacterial Agents (Antibiotics)IBA
11/2018 |
1 | 4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA
11/2018 |
1 | Evans Blue (Blue, Evans)FDA Link
01/2018 |
1 | CeruletideIBA
10/2017 |
1 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2017 |
1 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2016 |
1 | CarbamatesIBA
01/2016 |
1 | Histones (Histone)IBA
09/2015 |
1 | Phenobarbital (Luminal)FDA Link
05/2015 |
1 | Apolipoproteins E (ApoE)IBA
05/2015 |
1 | CholesterolIBA
05/2015 |
1 | Coloring Agents (Dyes)IBA
02/2015 |
1 | Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2015 |
1 | N,N- diethyl- 2- (2- (4- methoxyphenyl)- 5,7- dimethyl- pyrazolo(1,5- a)pyrimidin- 3- yl)- acetamideIBA
01/2015 |
1 | 2-deoxy-2-fluorosorbitolIBA
10/2014 |
1 | CyclamsIBA
08/2014 |
1 | N-(1,4,8,11- tetraazacyclotetradecanyl- 1,4- phenylenebis(methylene))- 2- (aminomethyl)- pyridineIBA
08/2014 |
1 | pyrimidineIBA
08/2014 |
1 | Chemokine ReceptorsIBA
08/2014 |
1 | Antigen Receptors (Antigen Receptor)IBA
02/2014 |
1 | Chelating AgentsIBA
08/2013 |
1 | Boronic AcidsIBA
06/2013 |
1 | GlutamatesIBA
05/2013 |
1 | Ethylene Glycol (Monoethylene Glycol)IBA
12/2012 |
1 | Adenosine Triphosphate (ATP)IBA
05/2012 |
1 | pyridineIBA
12/2011 |
1 | 2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA
12/2011 |
1 | Coenzyme A (CoA)IBA
05/2011 |
1 | Racemases and Epimerases (Epimerases and Racemases)IBA
05/2011 |
1 | Small Interfering RNA (siRNA)IBA
05/2011 |
1 | Gallium-68IBA
07/2010 |
1 | Acetates (Acetic Acid Esters)FDA Link
01/2010 |
1 | Androgen Receptors (Androgen Receptor)IBA
01/2010 |
1 | Choline (Choline Chloride)IBA
01/2010 |
1 | Glutamate Carboxypeptidase II (N-Acetylaspartylglutamate Peptidase)IBA
12/2008 |
1 | N- (N- ((S)- 1,3- Dicarboxypropyl)carbamoyl)- 4- (18F)fluorobenzyl- L- cysteineIBA
05/2008 |